Meridian Bioscience (VIVO +27.5%) is up on average volume in reaction to its announcement that
diagnostic companies and laboratories in China are using its Lyo-Ready
1-Step RT-qPCR Mix to develop screening tests for the 2019-nCoV
coronavirus causing the current outbreak of respiratory illnesses.
https://seekingalpha.com/news/3534704-meridian-bioscience-joins-coronavirus-rally-up-28
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.